These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 11717620)

  • 1. Results of Expert Meetings: Obesity and Cardiovascular Disease. Obesity, the metabolic syndrome, and cardiovascular disease.
    Vega GL
    Am Heart J; 2001 Dec; 142(6):1108-16. PubMed ID: 11717620
    [No Abstract]   [Full Text] [Related]  

  • 2. Dysmetabolic syndrome: multiple risk factors for premature adult disease in an adolescent girl.
    Falkner B; Hassink S; Ross J; Gidding S
    Pediatrics; 2002 Jul; 110(1 Pt 1):e14. PubMed ID: 12093995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity, insulin resistance, diabetes, and cardiovascular risk in children: an American Heart Association scientific statement from the Atherosclerosis, Hypertension, and Obesity in the Young Committee (Council on Cardiovascular Disease in the Young) and the Diabetes Committee (Council on Nutrition, Physical Activity, and Metabolism).
    Steinberger J; Daniels SR; ;
    Circulation; 2003 Mar; 107(10):1448-53. PubMed ID: 12642369
    [No Abstract]   [Full Text] [Related]  

  • 4. Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement From the American Heart Association.
    Bozkurt B; Aguilar D; Deswal A; Dunbar SB; Francis GS; Horwich T; Jessup M; Kosiborod M; Pritchett AM; Ramasubbu K; Rosendorff C; Yancy C;
    Circulation; 2016 Dec; 134(23):e535-e578. PubMed ID: 27799274
    [No Abstract]   [Full Text] [Related]  

  • 5. Medical consequences of obesity.
    Lawrence VJ; Kopelman PG
    Clin Dermatol; 2004; 22(4):296-302. PubMed ID: 15475229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of Expert Meetings: Obesity and Cardiovascular Disease. Obesity assessment.
    Khaodhiar L; Blackburn GL
    Am Heart J; 2001 Dec; 142(6):1095-101. PubMed ID: 11717618
    [No Abstract]   [Full Text] [Related]  

  • 7. Development of the multiple metabolic syndrome: an epidemiologic perspective.
    Liese AD; Mayer-Davis EJ; Haffner SM
    Epidemiol Rev; 1998; 20(2):157-72. PubMed ID: 9919436
    [No Abstract]   [Full Text] [Related]  

  • 8. Cardiovascular disease (CVD) risk factors in Samoa and American Samoa, 1990-95.
    McGarvey ST
    Pac Health Dialog; 2001 Mar; 8(1):157-62. PubMed ID: 12017817
    [No Abstract]   [Full Text] [Related]  

  • 9. Overweight and obesity: an overview of prevalence, clinical impact, and economic impact.
    Friedman N; Fanning EL
    Dis Manag; 2004; 7 Suppl 1():S1-6. PubMed ID: 15669572
    [No Abstract]   [Full Text] [Related]  

  • 10. What do we do about the problem of overweight and obesity in the Americas?
    Teelucksingh S
    Rev Panam Salud Publica; 2003 May; 13(5):275-6. PubMed ID: 12846232
    [No Abstract]   [Full Text] [Related]  

  • 11. Controversies on obesity and CKD.
    Ito S
    Circ J; 2010 Mar; 74(3):428-9. PubMed ID: 20145337
    [No Abstract]   [Full Text] [Related]  

  • 12. Results of Expert Meetings: Obesity and Cardiovascular Disease. Obesity as a risk factor in coronary artery disease.
    Rao SV; Donahue M; Pi-Sunyer FX; Fuster V
    Am Heart J; 2001 Dec; 142(6):1102-7. PubMed ID: 11717619
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiovascular risk factors in Saudi Arabian and non-Saudi Arabian diabetic patients in Saudi Arabia.
    Akbar DH; Ahmed MM; Algamdi AA
    East Mediterr Health J; 2003; 9(5-6):884-92. PubMed ID: 16450518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic syndrome.
    Virgin SE; Schmitke JA
    AAOHN J; 2003 Jan; 51(1):28-37. PubMed ID: 12596343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional disparities in cardiovascular risk factors in France: a five-year analysis of the GAZEL cohort.
    Tran PD; Leclerc A; Chastang JF; Goldberg M
    Eur J Epidemiol; 1998 Sep; 14(6):535-43. PubMed ID: 9794119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The metabolic syndrome and endothelial dysfunction: common highway to type 2 diabetes and CVD.
    Diamant M; Tushuizen ME
    Curr Diab Rep; 2006 Aug; 6(4):279-86. PubMed ID: 16879779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psoriasis as the marker of underlying systemic disease.
    Kourosh AS; Miner A; Menter A
    Skin Therapy Lett; 2008 Feb; 13(1):1-5. PubMed ID: 18357363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The prevalence of the metabolic syndrome in the Netherlands: increased risk of cardiovascular diseases and diabetes mellitus type 2 in one quarter of persons under 60].
    Bos MB; de Vries JH; Wolffenbuttel BH; Verhagen H; Hillege JL; Feskens EJ
    Ned Tijdschr Geneeskd; 2007 Oct; 151(43):2382-8. PubMed ID: 18019216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence of metabolic syndrome and Framingham cardiovascular risk scores in adult inpatients taking antipsychotics - a retrospective medical records review.
    Wysokiński A; Kowman M; Kłoszewska I
    Psychiatr Danub; 2012 Sep; 24(3):314-22. PubMed ID: 23013638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical implications of the metabolic syndrome.
    Ceska R
    Diab Vasc Dis Res; 2007 Sep; 4 Suppl 3():S2-4. PubMed ID: 17935057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.